Table 1.
The Concentrations of RBZ and 10×RBZ in the Anterior Chamber, Vitreous, Retina of Rabbit Eyes and Serum at 1 Hour and 1, 4, 8, 14, 30, and 60 Days after Injection
Anterior chamber Concentration (µg/mL) | Vitreous Concentration (µg/mL) | Retina Concentration (µg/mL) | Serum Concentration (ng/mL) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RBZ | 10×RBZ | RBZ | 10×RBZ | RBZ | 10×RBZ | RBZ | 10×RBZ | |||||
Time | 0.3 mg/0.03 mL | 3.0 mg/0.03 mL | P * value | 0.3 mg/0.03 mL | 3.0 mg/0.03 mL | P * value | 0.3 mg/0.03 mL | 3.0 mg/0.03 mL | P * value | 0.3 mg/0.03 mL | 3.0 mg/0.03 mL | P * value |
1 hour | 23.08 ± 6.11 | 181.48 ± 13.72 | < 0 .001 | 140.01 ± 10.85 | 1637.54 ± 132.74 | < 0 .001 | 76.48 ± 9.32 | 90.15 ± 6.40 | 0 .035 | 3.81 ± 0.52 | 19.73 ± 1.32 | < 0 .001 |
1 day | 14.08 ± 4.47 | 106.13 ± 9.64 | < 0 .001 | 100.61 ± 8.19 | 1192.33 ± 105.32 | < 0 .001 | 102.70 ± 11.27 | 112.90 ± 9.73 | 0.369 | 7.35 ± 1.14 | 22.07 ± 1.93 | < 0 .001 |
4 days | 8.69 ± 2.23 | 77.24 ± 8.48 | < 0 .001 | 51.72 ± 6.47 | 604.53 ± 48.78 | < 0 .001 | 72.26 ± 5.85 | 224.68 ± 15.77 | < 0 .001 | 4.56 ± 0.63 | 11.84 ± 1.46 | < 0 .001 |
8 days | 7.80 ± 2.06 | 64.40 ± 7.31 | < 0 .001 | 17.67 ± 4.26 | 450.87 ± 29.47 | < 0 .001 | 55.04 ± 4.46 | 83.80 ± 6.43 | 0 .001 | 2.08 ± 0.29 | 6.93 ± 0.82 | < 0 .001 |
14 days | 6.23 ± 1.83 | 17.08 ± 5.27 | < 0 .001 | 2.13 ± 0.44 | 171.32 ± 12.79 | < 0 .001 | 0.95 ± 0.17 | 9.36 ± 2.28 | < 0 .001 | 1.47 ± 0.17 | 4.58 ± 0.37 | < 0 .001 |
30 days | 0.02 | 0.08 ± 0.02 | < 0 .001 | 0 | 0.55 ± 0.11 | < 0 .001 | 0.16 ± 0.03 | 0.57 ± 0.11 | 0 .001 | 1.33 ± 0.18 | 3.37 ± 0.48 | < 0 .001 |
60 days | 0 | 0.01 | < 0 .001 | 0 | 0 | – | 0 | 0.33 ± 0.09 | < 0 .001 | 0 | 2.26 ± 0.31 | < 0 .001 |
10×RBZ, 10-fold ranibizumab; RBZ, ranibizumab.
P values in boldface indicate statistical significance.
Student's t-tests for P values